Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
2.28M
-
Shares change
-
+509K
-
Total reported value, excl. options
-
$14.4M
-
Value change
-
+$3.21M
-
Number of buys
-
11
-
Number of sells
-
-2
-
Price
-
$6.32
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q3 2019
14 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q3 2019.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.28M shares
of 26.8M outstanding shares and own 8.48% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (1.17M shares), AWM Investment Company, Inc. (483K shares), VANGUARD GROUP INC (258K shares), Diametric Capital, LP (163K shares), PRELUDE CAPITAL MANAGEMENT, LLC (73.9K shares), BlackRock Inc. (36.9K shares), First Allied Advisory Services, Inc. (36.1K shares), FIRST TRUST ADVISORS LP (24.6K shares), NORTHERN TRUST CORP (21.4K shares), and WELLS FARGO & COMPANY/MN (6K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.